Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wassmann

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Haematologica|June 15, 2007
First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemiaT Wolf, V Rickerts, S Staszewski, et al.
Leukemia|September 27, 2003
Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)B Wassmann, U Scheuring, H Pfeifer, et al.
Bone Marrow Transplantation|November 18, 1998
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsS Hohaus, H Martin, B Wassmann, et al.
Leukemia|November 28, 2002
Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)B Wassmann, H Pfeifer, U Scheuring, et al.
Bone Marrow Transplantation|April 15, 2003
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantationB Wassmann, U Scheuring, C Thiede, et al.
The Journal of Infectious Diseases|June 1, 1997
Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantationH Hebart, A Schröder, J Löffler, et al.
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, O G Ottmann, M Deininger, et al.
Leukemia|January 11, 2012
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemiaH Pfeifer, T Lange, S Wystub, et al.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Haematologica|June 15, 2007
First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemiaT Wolf, V Rickerts, S Staszewski, et al.
Leukemia|September 27, 2003
Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)B Wassmann, U Scheuring, H Pfeifer, et al.
Bone Marrow Transplantation|November 18, 1998
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsS Hohaus, H Martin, B Wassmann, et al.
Leukemia|November 28, 2002
Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)B Wassmann, H Pfeifer, U Scheuring, et al.
Bone Marrow Transplantation|April 15, 2003
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantationB Wassmann, U Scheuring, C Thiede, et al.
The Journal of Infectious Diseases|June 1, 1997
Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantationH Hebart, A Schröder, J Löffler, et al.
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, O G Ottmann, M Deininger, et al.
Leukemia|January 11, 2012
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemiaH Pfeifer, T Lange, S Wystub, et al.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Pageof 2